Skip to main content
Clinical Trials/NCT01502462
NCT01502462
Completed
Not Applicable

Prospective Registry of Patients With Isolated Severe Tricuspid Regurgitation

Asan Medical Center1 site in 1 country131 target enrollmentFebruary 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tricuspid Regurgitation
Sponsor
Asan Medical Center
Enrollment
131
Locations
1
Primary Endpoint
all cause death
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Prospective registry for patients with severe isolated tricuspid regurgitation (TR) without significant left-sided valvular or myocardial diseases.

Aim: To evaluate clinical course and prognostic factors of patients with severe isolated TR.

Detailed Description

Inclusion criteria Severe isolated TR for more than 6 months Exclusion criteria 1. Severe mitral and aortic valvular heart disease 2. Age equals to or more than 75 years 3. Malignancy or serious comorbidity with life expectancy \< 5years 4. Acute or subacute infective endocarditis requiring antibiotics therapy 5. Untreated hyperthyroidism 6. Constrictive pericarditis 7. Unclosed significant atrial septal defect 8. Previous tricuspid valve surgery 9. Significant coronary artery disease 10. Cardiomyopathy 11. Pregnancy 12. Severe resting pulmonary hypertension(TR Vmax \>4.0 m/s)

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
December 30, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jong-Min Song

Associate professor

Asan Medical Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

all cause death

Time Frame: 5 years

Secondary Outcomes

  • Hospitalization of cardiovascular causes(5 years)
  • tricuspid valve surgery(5 years)
  • stroke(5 years)

Study Sites (1)

Loading locations...

Similar Trials